Remove Academic Remove Aortic valve Remove Heart Valves
article thumbnail

Predictors of permanent pacemaker requirement in aortic stenosis patients undergoing self-expanding valve transcatheter aortic valve replacement using the cusp overlap technique

Frontiers in Cardiovascular Medicine

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV). Forty-seven received SEVs using COL, and 50 with CON techniques.

article thumbnail

Heart Valve Disease Forum 2023

Society of Thoracic Surgeons - Allied Health

The program directors have chosen an ambitious theme of "The Taming of the Aortic Valves," inspired by Shakespeare's classic The Taming of the Shrew. There will also be an in-depth discussion on the lifelong management of aortic valve surgery patients.

article thumbnail

Heart Valve Disease Forum 2024

Society of Thoracic Surgeons - Congenital

The conference theme is “Goldilocks: Toward the Optimal Mitral Valve,” and the organizers aim to bring together distinguished experts from around the world to share their knowledge and engage in academic discussions on the latest trends in treatments related to aortic valve disease. Details coming soon!

article thumbnail

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

DAIC

A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients. Francis Hospital , and faculty member at Columbia University. mmHg TAVR; 11.8

TAVR 52